The present invention relates to a method for treating non-melanotic cancers by administration of PABA. The present invention also relates to the potentiation of standard cancer treatment of radiation, radioimmunotherapy, and/or chemotherapy using PABA.

 
Web www.patentalert.com

< 2-methylene-19-nor-1.alpha.-hydroxy-17-ene-homopregnacalciferol and its uses

< Vitamin D.sub.3 analogues for the prevention and treatment of bone disorders

> Implantable device comprising phosphorus-containing macrolides

> Estrogen receptor modulators
~ 00602